Cargando…
Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children
Introduction: Surgical treatment of biliary atresia (BA) is still based on sequential strategy with Kasai hepatoportoenterostomy (KP) followed by liver transplantation (LT), in case of complicated secondary biliary cirrhosis. Concerns have been expressed regarding the risks of LT related to previous...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292612/ https://www.ncbi.nlm.nih.gov/pubmed/34307260 http://dx.doi.org/10.3389/fped.2021.697581 |
_version_ | 1783724861004185600 |
---|---|
author | Tambucci, Roberto de Magnée, Catherine Szabo, Margot Channaoui, Aniss Pire, Aurore de Meester de Betzenbroeck, Vanessa Scheers, Isabelle Stephenne, Xavier Smets, Françoise Sokal, Etienne M. Reding, Raymond |
author_facet | Tambucci, Roberto de Magnée, Catherine Szabo, Margot Channaoui, Aniss Pire, Aurore de Meester de Betzenbroeck, Vanessa Scheers, Isabelle Stephenne, Xavier Smets, Françoise Sokal, Etienne M. Reding, Raymond |
author_sort | Tambucci, Roberto |
collection | PubMed |
description | Introduction: Surgical treatment of biliary atresia (BA) is still based on sequential strategy with Kasai hepatoportoenterostomy (KP) followed by liver transplantation (LT), in case of complicated secondary biliary cirrhosis. Concerns have been expressed regarding the risks of LT related to previous KP, suggesting primary LT as an exclusive treatment of BA. Methods: Single-center retrospective analysis including 393 pediatric patients who underwent LT for BA from 1993 to 2018, categorized into two groups: with (KP) or without (NoKP) previous KP. Pre-LT clinical condition was estimated considering age at LT, time on waiting list, pediatric end-stage liver disease score (PELD), and presence of portal vein hypoplasia. Post-LT outcome was evaluated considering patient and graft survival rates, and need for early reoperation due to abdominal or graft-related complications (<45 days after LT). Results: Two-hundred ninety-six patients (75.3%) were categorized in the KP group, and 97 (24.7%) in the NoKP group. Median age at LT was 1.14 years in the KP group and 0.85 years in the NoKP group (p < 0.0001). PELD score was significantly less severe in KP patients (p < 0.05). One-year patient survival rates were 96.9 and 96.8% in the KP and NoKP groups, respectively (p = 0.43), and the corresponding graft survival was 92.5 and 94.8% (p = 0.97). The need for early reoperation was more frequent in the KP group (29.8%) vs. NoKP group (12.4%, p = 0.01). The rate of bowel perforation was non-significantly higher in the KP group (8.1%) vs. NoKP group (3.1%, p = 0.11). Conclusions: The sequential strategy including KP and LT allowed performing LT in patients with significant older age and better clinical conditions, when compared to those transplanted without previous KP. Patient and graft survivals were not impacted by previous KP. Although previous KP was associated with an increased rate of post-LT surgical complications, bowel perforation and bleeding did not occur significantly more frequently. Such results support the current strategy based on sequential treatment. |
format | Online Article Text |
id | pubmed-8292612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82926122021-07-22 Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children Tambucci, Roberto de Magnée, Catherine Szabo, Margot Channaoui, Aniss Pire, Aurore de Meester de Betzenbroeck, Vanessa Scheers, Isabelle Stephenne, Xavier Smets, Françoise Sokal, Etienne M. Reding, Raymond Front Pediatr Pediatrics Introduction: Surgical treatment of biliary atresia (BA) is still based on sequential strategy with Kasai hepatoportoenterostomy (KP) followed by liver transplantation (LT), in case of complicated secondary biliary cirrhosis. Concerns have been expressed regarding the risks of LT related to previous KP, suggesting primary LT as an exclusive treatment of BA. Methods: Single-center retrospective analysis including 393 pediatric patients who underwent LT for BA from 1993 to 2018, categorized into two groups: with (KP) or without (NoKP) previous KP. Pre-LT clinical condition was estimated considering age at LT, time on waiting list, pediatric end-stage liver disease score (PELD), and presence of portal vein hypoplasia. Post-LT outcome was evaluated considering patient and graft survival rates, and need for early reoperation due to abdominal or graft-related complications (<45 days after LT). Results: Two-hundred ninety-six patients (75.3%) were categorized in the KP group, and 97 (24.7%) in the NoKP group. Median age at LT was 1.14 years in the KP group and 0.85 years in the NoKP group (p < 0.0001). PELD score was significantly less severe in KP patients (p < 0.05). One-year patient survival rates were 96.9 and 96.8% in the KP and NoKP groups, respectively (p = 0.43), and the corresponding graft survival was 92.5 and 94.8% (p = 0.97). The need for early reoperation was more frequent in the KP group (29.8%) vs. NoKP group (12.4%, p = 0.01). The rate of bowel perforation was non-significantly higher in the KP group (8.1%) vs. NoKP group (3.1%, p = 0.11). Conclusions: The sequential strategy including KP and LT allowed performing LT in patients with significant older age and better clinical conditions, when compared to those transplanted without previous KP. Patient and graft survivals were not impacted by previous KP. Although previous KP was associated with an increased rate of post-LT surgical complications, bowel perforation and bleeding did not occur significantly more frequently. Such results support the current strategy based on sequential treatment. Frontiers Media S.A. 2021-07-07 /pmc/articles/PMC8292612/ /pubmed/34307260 http://dx.doi.org/10.3389/fped.2021.697581 Text en Copyright © 2021 Tambucci, de Magnée, Szabo, Channaoui, Pire, de Meester de Betzenbroeck, Scheers, Stephenne, Smets, Sokal and Reding. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Tambucci, Roberto de Magnée, Catherine Szabo, Margot Channaoui, Aniss Pire, Aurore de Meester de Betzenbroeck, Vanessa Scheers, Isabelle Stephenne, Xavier Smets, Françoise Sokal, Etienne M. Reding, Raymond Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children |
title | Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children |
title_full | Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children |
title_fullStr | Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children |
title_full_unstemmed | Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children |
title_short | Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children |
title_sort | sequential treatment of biliary atresia with kasai hepatoportoenterostomy and liver transplantation: benefits, risks, and outcome in 393 children |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292612/ https://www.ncbi.nlm.nih.gov/pubmed/34307260 http://dx.doi.org/10.3389/fped.2021.697581 |
work_keys_str_mv | AT tambucciroberto sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT demagneecatherine sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT szabomargot sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT channaouianiss sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT pireaurore sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT demeesterdebetzenbroeckvanessa sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT scheersisabelle sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT stephennexavier sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT smetsfrancoise sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT sokaletiennem sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children AT redingraymond sequentialtreatmentofbiliaryatresiawithkasaihepatoportoenterostomyandlivertransplantationbenefitsrisksandoutcomein393children |